Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age
Sharon Hui Xuan Tan, Alex R. Cook, Derrick Heng, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 6, pp. 525-532
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years
Atsuyuki Watanabe, Ryoma Kani, Masao Iwagami, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 4, pp. 384-384
Open Access | Times Cited: 60
Safety and effectiveness of vaccines against COVID-19 in children aged 5–11 years: a systematic review and meta-analysis
Vanessa Piechotta, Waldemar Siemens, Iris Thielemann, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 6, pp. 379-391
Open Access | Times Cited: 51
Changing patterns of infectious diseases in children during the COVID-19 pandemic
Ming‐Chun Yang, Yu‐Tsun Su, Ping-Hong Chen, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 45
Vaccine Effectiveness Against Long COVID in Children
Hanieh Razzaghi, Christopher B. Forrest, Kathryn Hirabayashi, et al.
PEDIATRICS (2024) Vol. 153, Iss. 4
Closed Access | Times Cited: 24
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study
Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J. Cowling, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. 421-434
Open Access | Times Cited: 52
School closures during COVID-19: an overview of systematic reviews
Samuel Hume, Samuel Robert Brown, Kamal R Mahtani
BMJ evidence-based medicine (2023) Vol. 28, Iss. 3, pp. 164-174
Open Access | Times Cited: 26
BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study
Chee Fu Yung, Deanette Pang, Kai‐Qian Kam, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 7, pp. 463-470
Open Access | Times Cited: 25
Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron BA.2 wave in Hong Kong
Daniel Leung, Jaime S. Rosa Duque, Ka Man Yip, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 23
Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational study
Alejandro Jara, Eduardo A. Undurraga, Juan Carlos Flores, et al.
The Lancet Regional Health - Americas (2023) Vol. 21, pp. 100487-100487
Open Access | Times Cited: 22
Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2–18 years: an updated systematic review and meta-analysis
Peng Gao, Liangyu Kang, Jue Liu, et al.
World Journal of Pediatrics (2023) Vol. 19, Iss. 11, pp. 1041-1054
Open Access | Times Cited: 21
Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents
Qiong Wu, Jiayi Tong, Bingyu Zhang, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 2, pp. 165-176
Open Access | Times Cited: 13
Vaccination against COVID-19 — risks and benefits in children
Alasdair Munro, Christine E. Jones, Saul N. Faust
European Journal of Pediatrics (2024) Vol. 183, Iss. 3, pp. 1107-1112
Open Access | Times Cited: 9
Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age
Farid Khan, Jennifer L. Nguyen, Tanya Singh, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2246915-e2246915
Open Access | Times Cited: 31
Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study
Juan Manuel Castelli, Analía Rearte, Santiago Olszevicki, et al.
BMJ (2022), pp. e073070-e073070
Open Access | Times Cited: 29
Decreased Clinical Severity of Pediatric Acute COVID-19 and MIS-C and Increase of Incidental Cases during the Omicron Wave in Comparison to the Delta Wave
Patrick Kenney, Arthur Chang, Lorna Krabill, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 180-180
Open Access | Times Cited: 19
Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study
D. Y. Lin, Yangjianchen Xu, Yu Gu, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. 1257-1265
Open Access | Times Cited: 19
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID
Tamás Constantin, Tamás Pék, Zsuzsanna Horváth, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2221-2236
Open Access | Times Cited: 17
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022
Lamprini Veneti, Jacob Dag Berild, Sara Viksmoen Watle, et al.
International Journal of Infectious Diseases (2023) Vol. 130, pp. 182-188
Open Access | Times Cited: 16
BNT162b2 Vaccine Effectiveness Against the SARS-CoV-2 Omicron Variant in Children Aged 5 to 11 Years
Eun Jung Jang, Young June Choe, Ryu Kyung Kim, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 3, pp. 319-319
Open Access | Times Cited: 15
The effect of COVID-19 vaccine to the Omicron variant in children and adolescents: a systematic review and meta-analysis
Wenting Lu, Shuai Zeng, Yuan Yao, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 6
Clinical characteristics of SARS-CoV-2-associated encephalopathy in children: Nationwide epidemiological study
Mariko Kasai, Hiroshi Sakuma, Yuichi Abe, et al.
Journal of the Neurological Sciences (2024) Vol. 457, pp. 122867-122867
Open Access | Times Cited: 5
Effectiveness and coverage of COVID-19 vaccination among the infection-naive population: A community-based retrospective cohort study in China
Yaqun Fu, Zhihu Xu, Quan Wang, et al.
Vaccine (2025) Vol. 50, pp. 126836-126836
Open Access
COVID-19 vaccine effectiveness in the paediatric population aged 5–17 years: a multicentre cohort study using electronic health registries in six European countries, 2021 to 2022
Patrícia Soares, Ausenda Machado, Nathalie Nicolay, et al.
Eurosurveillance (2025) Vol. 30, Iss. 8
Open Access
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland—A multicentre cohort study
Baharak Babouee Flury, Sabine Güsewell, Thomas Egger, et al.
PLoS Medicine (2022) Vol. 19, Iss. 11, pp. e1004125-e1004125
Open Access | Times Cited: 23
Respiratory Syncytial Virus, Influenza, and Coronavirus Disease 2019 Hospitalizations in Children in Colorado During the 2021-2022 Respiratory Virus Season
Suchitra Rao, Isaac Armistead, Amy Tyler, et al.
The Journal of Pediatrics (2023) Vol. 260, pp. 113491-113491
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top